Quadrant Capital Group LLC Csl LTD Transaction History

Quadrant Capital Group LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$79.09 - $114.05 $1.36 Million - $1.97 Million	-17,249 Closed	0 $0
Q4 2019 Feb 03, 2020	BUY	$77.9 - $98.54 $221,703 - $280,444	2,846 Added 19.76%	17,249 $1.65 Million
Q3 2019 Oct 24, 2019	BUY	$74.21 - $82.92 $67,234 - $75,125	906 Added 6.71%	14,403 $1.13 Million
Q2 2019 Jul 24, 2019	BUY	$68.24 - $75.87 $9,826 - $10,925	144 Added 1.08%	13,497 $1.01 Million
Q1 2019 Apr 29, 2019	BUY	$65.72 - $71.66 $228,114 - $248,731	3,471 Added 35.12%	13,353 $909,000
Q4 2018 Jan 17, 2019	BUY	$61.31 - $73.73 $213,787 - $257,096	3,487 Added 54.53%	9,882 $625,000
Q3 2018 Oct 29, 2018	SELL	$71.66 - $82.93 $20,853 - $24,132	-291 Reduced 4.35%	6,395 $448,000
Q2 2018 Aug 09, 2018	SELL	$58.93 - $74.24 $35,475 - $44,692	-602 Reduced 8.26%	6,686 $464,000
Q1 2018 May 10, 2018	SELL	$54.51 - $65.8 $283,506 - $342,225	-5,201 Closed	0 $0
Q4 2017 Jan 31, 2018	SELL	$52.25 - $56.32 $95,513 - $102,952	-1,828 Reduced 26.01%	5,201 $276,000
Q3 2017 Oct 13, 2017	BUY	$49.7 - $54.38 $13,518 - $14,791	272 Added 4.03%	7,029 $359,000
Q2 2017 Aug 15, 2017	BUY	N/A	6,757	6,757 $330,000

153K

Ticker CSLLY
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 964,432,000
Market Cap $85.6B
Description
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plas...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.